Background -In asthmatic subjects bronchoconstriction is induced by inhalation of the common food preservatives sulphur dioxide (SO2) and metabisulphite (MBS). SO2 and MBS challenges share many similarities, but it is not known whether they are equivalent. In this study of subjects with mild clinical asthma equivalence was assessed by comparing SO2 and MBS reactivity by estimating the total dose of SO2 inhaled during SO2 and MBS challenges, and by calculating SO2 uptake during both challenges. In addition, as the MBS solutions inhaled were acidic and hyperosmolar, the effect of these factors on MBS responsiveness was investigated. Methods -Fifteen subjects were challenged on separate days with doubling (0 5 to 8-0 ppm) concentrations of SO2 gas inhaled during three minute periods of isocapnic hyperventilation and MBS administered in doses ranging from 0-1 to 12-8 tmol using the Wright protocol. On two other days SO2 and MBS challenges were preceded by a challenge with phosphate buffered saline (PBS) solutions of pH and osmolarity similar to MBS solu-
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Background -In asthmatic subjects bronchoconstriction is induced by inhalation of the common food preservatives sulphur dioxide (SO2) and metabisulphite (MBS). SO2 and MBS challenges share many similarities, but it is not known whether they are equivalent. In this study of subjects with mild clinical asthma equivalence was assessed by comparing SO2 and MBS reactivity by estimating the total dose of SO2 inhaled during SO2 and MBS challenges, and by calculating SO2 uptake during both challenges. In addition, as the MBS solutions inhaled were acidic and hyperosmolar, the effect of these factors on MBS responsiveness was investigated. Methods -Fifteen subjects were challenged on separate days with doubling (0 5 to 8-0 ppm) concentrations of SO2 gas inhaled during three minute periods of isocapnic hyperventilation and MBS administered in doses ranging from 0-1 to 12-8 tmol using the (Thorax 1994; 49:250-256) Sulphiting agents such as sodium metabisulphite (MBS) and sulphur dioxide (SO2) are commonly used as food and wine preservatives. In subjects with asthma ingestion of foods and beverages containing these agents can provoke bronchoconstriction,' but bronchoconstriction develops more frequently following inhalation of either SO2 gas2 or metabisulphite aerosols3 which are commonly used in the laboratory to assess sensitivity to sulphiting agents. Many characteristics of the airway responses to SO2 and MBS are similar,4 so the mechanism by which inhaled MBS provokes bronchoconstriction has been attributed to SO2 released from MBS aerosols, and S02 and MBS challenges have been considered to be equivalent. However, the effect of inhaled MBS may not be solely due to liberated SO2.
In solution MBS also converts to bisulphite, another potent bronchoconstricting stimulus, and MBS induced bronchoconstriction may be caused by the bisulphite ions in the aerosols acting alone, or together with generated SO2.5 Some of the mechanisms by which SO2 and MBS provoke bronchoconstriction appear to be similar, but there are also differences. Nedocomil sodium inhibits bronchoconstriction induced by both SO26 and MBS,4 but while anticholinergic agents have no effect on the response to MBS,7 in at least 30% of asthmatic subjects SO2 induced bronchoconstriction is cholinergically mediated.28
The aim of this study was to determine whether the bronchoconstrictions induced by inhalation of S02 and MBS were similar. This was first examined by comparing the provocative concentration of S02 and dose of MBS which caused FEVI to fall by more than 20% from baseline. Secondly, to determine whether SO2 and MBS challenges were equivalent in terms of the amount of SO2 inhaled the concentration of SO2 delivered during an SO2 challenge, and the concentration released and inhaled during an MBS challenge, were compared. Thirdly, the uptake of SO2 gas during MBS and SO2 challenges was estimated and the values compared. Lastly, as the MBS challenge protocol used in this study involved dissolving it in acidic, hyperosmolar solutions, it was important to determine whether these properties of MBS solutions affected responses to MBS, and therefore the comparison between MBS and SO2 airway responses.
Methods

DOSE-RESPONSE STUDIES
Fifteen clinically stable subjects (seven women, eight men) aged 18-53 years were studied (table 1) . Twelve subjects were atopic on skin prick testing and all were non-smokers. Four subjects were taking regular inhaled steroids (beclomethasone 400-1000 gg daily) and all used a 02 agonist as required. Baseline
Comparison of sulphur dioxide and metabisulphite airway reactivity in asthma A constant VE was maintained by subjects breathing in time to a metronome and inhaling a constant tidal volume, with each subject being cued by watching their respiration on a visual display unit. Subjects inhaled a constant tidal volume of either 1 0 or 1-5 1 depending on total lung capacity.
Metabisulphite challenge Metabisulphite challenges were administered with the protocol described by Wright et al. 4 Sodium metabisulphite solutions were made up in phosphate buffered saline (PBS) in concentrations of 6-2, 12-5, 50, and 100 mg/ml. The doses of MBS administered were 0 1, 0-2, 0 4, 0-8, 1-6, 3-2, 6-4, and 12-8 pmol. Aerosols were delivered with De Vilbiss No. 40 hand held nebulisers (DeVilbiss Corporation, Somerset, Pennsylvania, USA) and all challenges were performed within 30 minutes of preparing the solutions. After inhaling a control aerosol of PBS, increasing doses of MBS were inhaled at three minute intervals. The challenge ended when FEV1 fell by 20% or more from the control measurement, or when the maximal dose had been administered. The pH and osmolarity of the MBS solutions were 6 56 and 415 mosmol in the 6-25 mg/ml solution, 6 -26 and 520 mosmol in the 12-5 mg/ml solution, and 1160 mosmol in the 6-4 mg/ ml solution, and 4-95 and 1960 mosmol in the 12-8 mg/ml solution.
PBS and histamine challenges Phosphate buffered saline challenges involved inhalation of solutions of increasing osmolarity, pH and titratable acidity, equivalent to the MBS solutions, using the MBS challenge protocol described above. The osmolarity and pH of the MBS and control PBS solutions are shown in table 2.
Histamine challenges were carried out as described by Yan and coworkers.9 Histamine Mean of logl0 MBS PD20 and PMBS PD20 values Figure 1 Relation in each subject (n= 15) between the mean of log10 PD20 values following challenge with metabisulphite (MBS) and challenge with phosphate buffered saline followed by MBS (PMBS), and the difference between log,0 PD20 MBS and log,0 PD20 PMBS. PD20 MBS is the dose of MBS producing a 20% fall in FEV,. following challenge with PBS ( S02 PC20 (PPM) Figure 4 Relation between the PC,0 for sulphur dioxide (SO,) (ppm) and the PD,0 for histamine (pumol) in 15 asthmatic subjects.
change differed significantly from a mean fall in FEV1 of 9-3 (0-6)% which occurred when only the final concentration of SO2 was inhaled.
The mean concentrations of SO2 released by the 6-2, 12-5, 50, and 100 mg/ml solutions of MBS were 1-3 (0-14) ppm (range 0-9-1-4), 192 (O-13)ppm (range 1-8-2 -1), [18] [19] [20] [21] [22] [23] [24] (1-65) ppm (range [17] [18] [19] [20] [21] Relation between the PD,0 for metabisulphite (MBS) (pumol) and the PD,0 for histamine (pmol). measured on exhalation after inhalation of each MBS dose was 0 5 ppm. When a dose of MBS involved more than one inhalation the concentration of S02 in exhaled samples was the same, either when measured after each inhalation or when measured after the final inhalation. The estimated uptake of SO2 was 60% for a 01 Itmol dose of MBS, 75% for 0-2, 0-4, and 0-8 pmol doses, and between 95% and 97% for 1 6, 3-2, 6 4, and 12-8 pmol doses of MBS. Uptake of S02 was 80% for all S02 concentrations.
When these results were used to estimate S02 uptake it was calculated that, during MBS challenges, S02 uptake ranged from 43 to 377 ppm with a mean of 165 ppm (95% CI 116 to 214). This differed significantly (p <0 001) from the uptake of S02 during S02 challenges, when estimates ranged from 140 to 1860 ppm with a mean of 765 ppm (95% CI 450 to 1080).
Discussion
Although inhalation of nebulised MBS is thought to provoke bronchoconstriction via generated S02, no relation between S02 and MBS airway responsiveness was found in this study. However, as all subjects recruited reacted to relatively high doses of both MBS and S02, airway reactivity to MBS and S02 may be related in subjects more sensitive to both agents. In addition, as a small number of subjects were studied, the failure to find a relation between S and MBS responsiveness may have been due to a type II error.
The properties of aerosols which can cause airway narrowing in asthmatic subjects include the osmolarity, pH, and titratable acidity. 112 Bronchoconstriction is provoked by inhalation of hyperosmolar solutions'2 and by inhalation of acidic solutions, with buffered acidic solutions inducing more severe airway narrowing than unbuffered solutions." The MBS solutions administered in this study were hyperosmolar and acidic and were also buffered by phosphate saline. However, when subjects inhaled PBS solutions of osmolarity, pH, and titratable acidity equivalent to the MBS solutions, no bronchoconstriction was observed. These results are supported by the findings of Wright et al4 who partially investigated whether the properties of MBS solutions affected MBS responses. In their study five asthmatic subjects did not bronchoconstrict after challenge with saline solutions of osmolarity equivalent to the MBS solutions.
The acidic, hyperosmolar properties of the PBS solutions did not appear to potentiate airway responsiveness. There was no difference between S02 PC20 values obtained when an S02 challenge was performed alone or preceded by a PBS challenge and, similarly, an initial PBS challenge did not affect MBS responsiveness. It is most likely that the properties of the solution in which MBS was dissolved did not affect the response to MBS because the quantity of aerosol adminstered was so small. In studies investigating the bronchoconstrictive potential of hyperosmolar aerosols'213 and acidic aerosols" the minimum volume inhaled has been 2 ml. The mean output of DeVilbiss nebulisers used in this study was 0 018 ml per puff and, therefore, during an MBS challenge the greatest amount of aerosol administered was only 0 14 ml.
The lack of a relation between S02 and MBS airway responsiveness and the lower estimates of the amount of S02 inhaled and absorbed during MBS challenges suggest that MBS induced bronchoconstriction is not solely due to generated S02. When MBS is dissolved in solution it reacts chemically to form bisulphite and sulphite and S02 is generated. These substances enter into equilibrium with each other, with more acidic solutions favouring generation of S02. Bisulphite and S02 are potent bronchoconstricting agents, whereas sulphite has only a weak effect.' During MBS challenges aerosolised bisulphite and generated S02 are highly reactive and it is likely that these bronchoconstricting stimuli continue to interact after inhalation. Bronchoconstriction could result from bisulphite ions deposited directly in the airways or formed locally from dissolved S02 gas and from S02, either inhaled or generated from bisulphite in the airways. In contrast, during S02 challenges, when a constant concentration of S02 is inhaled, S02 is quickly absorbed in the aqueous environment of the airways.'4 At the pH of human airways, which averages 6 6,'5 it is likely that most of the inhaled S02 rapidly converts to bisulphite.'6 Thus, both SO2 and bisulphite probably play a part in S02 and MBS induced bronchoconstriction, but the contribution of each stimulus to each challenge differs. Such a difference may underlie the lack of a relation between S02 and MBS challenges.
Sulphur dioxide is almost completely absorbed when inhaled via the nose,'4 but when inhaled via the mouth absorption of S02 is altered by the concentration of S02 administered and, more importantly, by the rate of administration.'4'8 When 1 ppm and 10 ppm S02 were administered to rabbits S02 absorption decreased from 99 5% to 96-3%, but following a tenfold increase in the rate of administration S02 absorption fell to 66%. '9 In our study it was estimated that 80% of each concentration of S02 inhaled was absorbed. This uniform amount of absorption was most probably due to the rate of administration of S02 which was inhaled at an average VE of 40 1/min. Factors which could influence absorption of S02 or bisulphite ions generated during MBS 
